Symbols / FLXN
FLXN Chart
About
The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund’s Fixed Income Instruments may include debt or debt-related securities, income producing securities, and other instruments or evidences of indebtedness, including bonds, bills, notes, loans, money market instruments, mortgage and asset backed securities, and preferred stocks, and derivative instruments related thereto; and other investment companies that invest primarily in the foregoing instruments.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | 27.96 | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 26.09 | 52W Low | 24.92 |
| Beta | — | Avg Volume | 5.14K | Volume | 1.91K |
| Target Price | — | Recom | — | Prev Close | $25.68 |
| Price | $25.70 | Change | 0.08% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
No analyst ratings or price targets available.
- Why A Key Drug Launch Wasn't Enough To Help This Biotech Stock - Investor's Business Daily Mon, 12 Mar 2018 07
- Flexion and Adamas Are Being Acquired. Both Stocks Are Soaring. - Barron's Mon, 11 Oct 2021 07
- Pacira BioSciences To Buy Flexion Therapeutics - Quick Facts - Nasdaq Mon, 11 Oct 2021 07
- Pacira Biosciences Will Acquire Flexion Therapeutics in $427.5M Deal - Law Street Media hu, 21 Oct 2021 07
- 5 'Strong Buy' Biotech Stocks to Buy for 2020 - Kiplinger Wed, 29 Jan 2020 08
- Biotech Stocks Facing FDA Decision In October - RTTNews hu, 07 Feb 2019 21
- November 28th Options Now Available For SoFi Technologies (SOFI) - Nasdaq hu, 09 Oct 2025 07
- Constellation Brands Named Top Dividend Stock With Insider Buying and 2.33% Yield (STZ) - Nasdaq Wed, 23 Jul 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for FLXN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|